{"id":"https://openalex.org/W3212907973","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.203","title":"203 A membrane-tethered IL-15/IL-15 receptor fusion protein enhances the persistence and efficacy of CD70-targeted TRuC-T cells","display_name":"203 A membrane-tethered IL-15/IL-15 receptor fusion protein enhances the persistence and efficacy of CD70-targeted TRuC-T cells","publication_year":2021,"publication_date":"2021-11-01","ids":{"openalex":"https://openalex.org/W3212907973","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.203","mag":"3212907973"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2021-sitc2021.203","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.203","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2021-sitc2021.203","pdf_url":"https://jitc.bmj.com/content/jitc/9/Suppl_2/A214.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/9/Suppl_2/A214.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101518854","display_name":"Jian Ping Ding","orcid":"https://orcid.org/0000-0001-8216-9392","observed_orcids":["https://orcid.org/0000-0001-8216-9392"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jian Ding","raw_affiliation_strings":["TCR2 Therapeutics, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TCR2 Therapeutics, Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000336280","display_name":"Lindsay Webb","orcid":"https://orcid.org/0000-0002-3204-568X","observed_orcids":["https://orcid.org/0000-0002-3204-568X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lindsay Webb","raw_affiliation_strings":["TCR2 Therapeutics, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TCR2 Therapeutics, Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028512226","display_name":"Troy D. Patterson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Troy Patterson","raw_affiliation_strings":["TCR2 Therapeutics, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TCR2 Therapeutics, Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Michelle Fleury","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michelle Fleury","raw_affiliation_strings":["TCR2 Therapeutics, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TCR2 Therapeutics, Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020556821","display_name":"Adam Zieba","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Adam Zieba","raw_affiliation_strings":["TCR2 Therapeutics, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TCR2 Therapeutics, Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009657522","display_name":"Holly M. Horton","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Holly Horton","raw_affiliation_strings":["TCR2 Therapeutics, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TCR2 Therapeutics, Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112172747","display_name":"Robert Hofmeister","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert Hofmeister","raw_affiliation_strings":["TCR2 Therapeutics, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TCR2 Therapeutics, Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103985200","display_name":"Dario A. Gutierrez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dario Gutierrez","raw_affiliation_strings":["TCR2 Therapeutics, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TCR2 Therapeutics, Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023615653","display_name":"Robert Tighe","orcid":"https://orcid.org/0009-0005-8406-0709","observed_orcids":["https://orcid.org/0009-0005-8406-0709"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert Tighe","raw_affiliation_strings":["TCR2 Therapeutics, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"TCR2 Therapeutics, Cambridge, MA, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A214","last_page":"A214"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9624000191688538,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.9624000191688538,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.018799999728798866,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.011099999770522118,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/il-15","display_name":"IL-15","score":0.8140000104904175},{"id":"https://openalex.org/keywords/cd70","display_name":"CD70","score":0.7620000243186951},{"id":"https://openalex.org/keywords/adoptive-t-cell-therapy","display_name":"adoptive T cell therapy","score":0.8199999928474426},{"id":"https://openalex.org/keywords/t-cell-persistence","display_name":"T cell persistence","score":0.7789999842643738},{"id":"https://openalex.org/keywords/activation-induced-cell-death","display_name":"activation-induced cell death","score":0.7570000290870667},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.5540000200271606},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.6349999904632568},{"id":"https://openalex.org/keywords/interleukin-7","display_name":"IL-7","score":0.5239999890327454}],"concepts":[{"id":"https://openalex.org/C148125776","wikidata":"https://www.wikidata.org/wiki/Q1622348","display_name":"CD28","level":4,"score":0.6564918160438538},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.5961512327194214},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.5432870984077454},{"id":"https://openalex.org/C3875195","wikidata":"https://www.wikidata.org/wiki/Q5099363","display_name":"Chimeric antigen receptor","level":4,"score":0.5114868879318237},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.4815271496772766},{"id":"https://openalex.org/C51785407","wikidata":"https://www.wikidata.org/wiki/Q2627568","display_name":"Effector","level":2,"score":0.4494754672050476},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4353259205818176},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.4314754009246826},{"id":"https://openalex.org/C19317047","wikidata":"https://www.wikidata.org/wiki/Q412037","display_name":"T-cell receptor","level":4,"score":0.4237882196903229},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4132888913154602},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3441004753112793},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.34202855825424194}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/jitc-2021-sitc2021.203","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.203","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2021-sitc2021.203","pdf_url":"https://jitc.bmj.com/content/jitc/9/Suppl_2/A214.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2021-sitc2021.203","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.203","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2021-sitc2021.203","pdf_url":"https://jitc.bmj.com/content/jitc/9/Suppl_2/A214.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3212907973.pdf","grobid_xml":"https://content.openalex.org/works/W3212907973.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4205658792","https://openalex.org/W4410905096","https://openalex.org/W3213049140","https://openalex.org/W3179056516","https://openalex.org/W4404053139","https://openalex.org/W4388140661","https://openalex.org/W4362595978","https://openalex.org/W2556133499","https://openalex.org/W4309515333","https://openalex.org/W11502152"],"abstract_inverted_index":{"Background":[0],"Adoptive":[1],"cell":[2,17,26,40,86,128,137,187,288],"therapies":[3,18],"have":[4,23,57],"shown":[5],"great":[6],"promise":[7],"in":[8,19,74,91,172,200,205,245,292,342,386],"hematological":[9,78],"malignancies.":[10,79],"To":[11],"realize":[12],"the":[13,59,92,118,157,161,164,179,185,234,238,271,280,286,293,301,317,330,366,369,381,407,418],"potential":[14],"of":[15,53,64,124,178,213,224,237,273,282,333,358,365,375,383],"T":[16,25,31,39,85,127,141,186,207,241,274,360],"solid":[20,76,391],"tumors,":[21],"we":[22,56,96],"developed":[24],"receptor":[27,41],"fusion":[28,106],"construct":[29],"(TRuC\u00ae)":[30],"cells,":[32,378],"which":[33,206],"are":[34],"equipped":[35],"with":[36,151,221,312,349,388],"an":[37],"engineered":[38,97],"that":[42,116],"utilizes":[43],"all":[44],"TCR":[45],"signaling":[46],"subunits":[47],"and":[48,61,77,89,121,130,148,160,181,184,230,260,267,307,322,346,354,372,392,425],"recognizes":[49],"tumor-associated":[50],"antigens":[51],"independent":[52],"HLA.":[54],"Previously,":[55],"described":[58],"discovery":[60],"preclinical":[62],"efficacy":[63,236],"fratricide-resistant":[65],"TRuC-T":[66,99,287,298,335,377],"cells":[67,100,142,165,208,217,242,284,299,336],"targeting":[68],"CD70,":[69],"a":[70,81,103,111,152,201,355,414],"tumor":[71,94,254,344],"antigen":[72],"overexpressed":[73],"various":[75],"As":[80],"strategy":[82],"to":[83,101,133],"enhance":[84],"effector":[87,122],"function":[88,123],"persistence":[90,197,308,323],"hostile":[93],"microenvironment,":[95],"anti-CD70":[98,158,239,258],"co-express":[102],"membrane-bound":[104],"IL15Ra-IL15":[105],"protein":[107],"(IL-15fu).":[108],"IL-15":[109],"is":[110],"common":[112],"?":[113],"chain":[114],"cytokine":[115,228],"promotes":[117],"differentiation,":[119],"maintenance,":[120],"memory":[125,188],"CD8+":[126,294,359],"subsets":[129],"confers":[131],"resistance":[132],"IL-2-mediated":[134],"activation":[135],"induced":[136],"death":[138],"(AICD).":[139],"Methods":[140],"were":[143,166,209,400],"activated":[144],"by":[145,192,211,340,402,417],"CD3/CD28":[146],"stimulation":[147,203,311],"lentivirally":[149],"transduced":[150],"T2A-containing":[153],"bicistronic":[154],"vector":[155],"encoding":[156],"CD3?-TRuC":[159],"IL-15fu":[162,182,261,277,302,318,341,367],"proteins;":[163],"further":[167],"expanded":[168],"for":[169],"9":[170],"days":[171,220],"media":[173],"containing":[174],"IL-7/IL-15.":[175],"Surface":[176],"co-expression":[177,269],"TRuC":[180,259],"proteins":[183,262],"phenotype":[189],"was":[190,198,243,337,347],"assessed":[191],"flow":[193],"cytometry.":[194],"In":[195,232,296,328],"vitro":[196],"tested":[199],"repeated":[202,310],"assay":[204],"challenged":[210],"addition":[212,364],"fresh":[214],"CD70+":[215,313],"target":[216,314],"every":[218],"four":[219],"longitudinal":[222],"assessment":[223],"T-cell":[225,320,352],"expansion,":[226],"phenotype,":[227,370],"production,":[229],"cytotoxicity.":[231],"vivo,":[233,329],"antitumor":[235],"TRuC/IL-15fu":[240],"evaluated":[244],"MHC":[246],"class":[247],"I/II":[248],"deficient":[249],"NSG":[250],"mice":[251],"bearing":[252,300],"human":[253],"xenografts.":[255],"Results":[256],"The":[257,276,363],"showed":[263,303],"high":[264],"transduction":[265],"efficiency":[266],"robust":[268],"on":[270],"surface":[272],"cells.":[275,315,361],"significantly":[278,338],"increased":[279],"proportion":[281],"na\u00efve":[283],"within":[285],"product,":[289],"most":[290],"dramatically":[291],"subset.":[295],"vitro,":[297],"greatly":[304],"enhanced":[305,319,350],"expansion":[306,357],"upon":[309],"Moreover,":[316],"survival":[321],"under":[324,413],"unstimulated,":[325],"cytokine-free":[326],"conditions.":[327],"anti-tumor":[331,373],"activity":[332,374],"CD70-targeted":[334,376],"improved":[339,368],"multiple":[343],"models":[345],"associated":[348],"intratumoral":[351],"accumulation":[353],"preferential":[356],"Conclusions":[362],"persistence,":[371],"potentially":[379],"increasing":[380],"likelihood":[382],"clinical":[384],"benefit":[385],"patients":[387],"CD70":[389],"overexpressing":[390],"liquid":[393],"cancers.":[394],"Ethics":[395],"Approval":[396],"All":[397],"animal":[398],"studies":[399],"conducted":[401],"TCR2":[403],"Therapeutics":[404],"staff":[405],"at":[406],"Charles":[408,419],"River":[409,420],"Laboratories":[410,421],"CRADL":[411],"facility":[412],"protocol":[415],"approved":[416],"Institutional":[422],"Animal":[423],"Care":[424],"Use":[426],"Committee.":[427]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-11-13T13:42:25.865203","created_date":"2021-11-22T00:00:00"}